| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |